"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A2,WO 2007/058675 A2,194-336-540-268-302,2007-05-24,2007,US 2006/0020184 W,2006-05-25,US 68499005 P,2005-05-27,PHOTOLUMINESCENT (PL) WEAPON SIGHT ILLUMINATOR,"Methods and systems are described herein for an article of manufacture for use in a weapon sight wherein the article of manufacture comprises a passively charged photoluminescent material. When installed in a weapon sight, the passively charged photoluminescent material provides light to a fiber optic of the weapon sight during low light conditions to illuminate a reticle pattern of the weapon sight.",DEFENSE HOLDINGS INC;;BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,,https://lens.org/194-336-540-268-302,Patent Application,yes,0,12,6,6,0,F41G1/345;;F41G1/345,F41G1/01,,0,0,,,,PENDING
2,US,A1,US 2010/0170136 A1,187-545-373-558-544,2010-07-08,2010,US 72432410 A,2010-03-15,US 72432410 A;;US 44009706 A;;US 68499005 P,2005-05-27,PHOTOLUMINESCENT (PL) WEAPON SIGHT ILLUMINATOR,"Methods and systems are described herein for an article of manufacture for use in a weapon sight wherein the article of manufacture comprises a passively charged photoluminescent material. When installed in a weapon sight, the passively charged photoluminescent material provides light to a fiber optic of the weapon sight during low light conditions to illuminate a reticle pattern of the weapon sight.",DEFENSE HOLDINGS INC,BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,,https://lens.org/187-545-373-558-544,Patent Application,yes,24,8,6,6,0,F41G1/345;;F41G1/345,F21V9/16;;F41G1/34;;F41G1/00;;G02B6/00;;G02B6/04;;G09F13/20,42/132;;40/542;;362/84;;362/551;;362/554,0,0,,,,ACTIVE
3,US,B2,US 8425063 B2,173-830-653-441-935,2013-04-23,2013,US 72432410 A,2010-03-15,US 72432410 A;;US 44009706 A;;US 68499005 P,2005-05-27,Photoluminescent (PL) weapon sight illuminator,"Methods and systems are described herein for an article of manufacture for use in a weapon sight wherein the article of manufacture comprises a passively charged photoluminescent material. When installed in a weapon sight, the passively charged photoluminescent material provides light to a fiber optic of the weapon sight during low light conditions to illuminate a reticle pattern of the weapon sight.",BUCKINGHAM THOMAS MARTIN;;JONES HERBERT;;DEFENSE HOLDINGS INC,BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,,https://lens.org/173-830-653-441-935,Granted Patent,yes,70,5,6,6,0,F41G1/345;;F41G1/345,F21K2/00,362/34;;362/84;;362/551;;362/577;;362/582;;362/583;;42/113;;42/122;;42/123;;42/130;;42/131;;42/132;;359/424;;359/428,0,0,,,,ACTIVE
4,WO,A3,WO 2007/058675 A3,117-061-523-108-291,2007-11-15,2007,US 2006/0020184 W,2006-05-25,US 68499005 P,2005-05-27,PHOTOLUMINESCENT (PL) WEAPON SIGHT ILLUMINATOR,"Methods and systems are described herein for an article of manufacture for use in a weapon sight wherein the article of manufacture comprises a passively charged photoluminescent material. When installed in a weapon sight, the passively charged photoluminescent material provides light to a fiber optic of the weapon sight during low light conditions to illuminate a reticle pattern of the weapon sight.",DEFENSE HOLDINGS INC;;BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,,https://lens.org/117-061-523-108-291,Search Report,yes,5,0,6,6,0,F41G1/345;;F41G1/345,F41G1/32,,0,0,,,,PENDING
5,ZA,B,ZA 883665 B,112-761-301-054-940,1989-03-29,1989,ZA 883665 A,1988-05-23,GB 8712107 A,1987-05-22,FILLERS,,ICI PLC,EVANS MARTIN BUCKINGHAM;;MARTIN BUCKINGHAM EVANS;;ROTHON ROGER NORMAN;;ROGER NORMAN ROTHON,,https://lens.org/112-761-301-054-940,Granted Patent,no,0,0,2,13,0,,C08K/;;C08L/,,0,0,,,,EXPIRED
6,US,A1,US 2008/0295380 A1,179-985-182-813-337,2008-12-04,2008,US 44009706 A,2006-05-25,US 44009706 A;;US 68499005 P,2005-05-27,Photoluminescent (PL) weapon sight illuminator,"Methods and systems are described herein for an article of manufacture for use in a weapon sight wherein the article of manufacture comprises a passively charged photoluminescent material. When installed in a weapon sight, the passively charged photoluminescent material provides light to a fiber optic of the weapon sight during low light conditions to illuminate a reticle pattern of the weapon sight.",DEFENSE HOLDINGS INC,BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,DEFENSE HOLDINGS INC (2006-05-19),https://lens.org/179-985-182-813-337,Patent Application,yes,45,18,6,6,0,F41G1/345;;F41G1/345,F21K2/00;;F41G1/00,42/131;;250/462.1,0,0,,,,ACTIVE
7,US,B2,US 7676981 B2,106-283-007-125-145,2010-03-16,2010,US 44009706 A,2006-05-25,US 44009706 A;;US 68499005 P,2005-05-27,Photoluminescent (PL) weapon sight illuminator,"Methods and systems are described herein for an article of manufacture for use in a weapon sight wherein the article of manufacture comprises a passively charged photoluminescent material. When installed in a weapon sight, the passively charged photoluminescent material provides light to a fiber optic of the weapon sight during low light conditions to illuminate a reticle pattern of the weapon sight.",DEFENSE HOLDINGS INC,BUCKINGHAM THOMAS MARTIN;;JONES HERBERT,DEFENSE HOLDINGS INC (2006-05-19),https://lens.org/106-283-007-125-145,Granted Patent,yes,51,13,6,6,0,F41G1/345;;F41G1/345,F41G1/00,42/132;;42/123;;42/130;;42/131,0,0,,,,ACTIVE
8,AU,B2,AU 615653 B2,073-258-018-947-574,1991-10-10,1991,AU 1988/016516 A,1988-05-20,GB 8712107 A;;GB 8714916 A,1987-05-22,FILLERS,,ICI PLC,EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/073-258-018-947-574,Granted Patent,no,1,0,10,13,0,C08K9/08;;C08K9/08,C08L23/16;;C08K9/00;;C08K9/04;;C08K9/08,,0,0,,,,EXPIRED
9,AU,A,AU 1988/016516 A,133-736-758-266-49X,1988-11-24,1988,AU 1988/016516 A,1988-05-20,GB 8712107 A;;GB 8714916 A,1987-05-22,FILLERS,,ICI PLC,EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/133-736-758-266-49X,Patent Application,no,0,1,10,13,0,C08K9/08;;C08K9/08,C08L23/16;;C08K9/00;;C08K9/04;;C08K9/08,,0,0,,,,EXPIRED
10,US,A1,US 2005/0052880 A1,079-725-443-567-116,2005-03-10,2005,US 62318603 A,2003-07-21,US 62318603 A;;US 39701702 P,2002-07-22,Low light level illumination for rotating objects,Low light level illumination is applied to rotary blades of vehicles to increase visibility to minimize ground injuries. Either photoluminescent paint or photoluminescent film may be affixed to rotary blades in use to help deter accidents. An electro-luminescent film may be integrated into future rotary blades to provide greater visibility without making the vehicle vulnerable to detection.,BUCKINGHAM THOMAS MARTIN;;ELGER WALLACE M.,BUCKINGHAM THOMAS MARTIN;;ELGER WALLACE M,DEFENSE HOLDINGS INC (2007-11-27),https://lens.org/079-725-443-567-116,Patent Application,yes,12,13,13,13,0,B64C11/16;;B64C11/16;;B64C27/46;;B64C27/46;;C09D5/22;;C09D5/22,B64C11/16;;B64C27/46;;B64D47/02;;B64F1/20;;C09D5/22;;C09K/;;F21K2/00;;G01N21/84,362/471,0,0,,,,EXPIRED
11,BR,A,BR 8802516 A,138-980-470-658-79X,1988-12-20,1988,BR 8802516 A,1988-05-23,GB 8712107 A;;GB 8714916 A,1987-05-22,MATRIZ DE POLIMERO COESIVO E PROCESSO PARA A PRODUCAO DE UMA MATRIZ,,ICI PLC,EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/138-980-470-658-79X,Patent Application,no,0,0,10,13,0,C08K9/08;;C08K9/08,C08L23/16;;C08K9/00;;C08K9/04;;C08K9/08,,0,0,,,,DISCONTINUED
12,US,B2,US 7326435 B2,192-363-604-565-164,2008-02-05,2008,US 62318603 A,2003-07-21,US 62318603 A;;US 39701702 P,2002-07-22,Method of illuminating a rotary blade by application of a photoluminescent paint,Low light level illumination is applied to rotary blades of vehicles to increase visibility to minimize ground injuries. Either photoluminescent paint or photoluminescent film may be affixed to rotary blades in use to help deter accidents. An electro-luminescent film may be integrated into future rotary blades to provide greater visibility without making the vehicle vulnerable to detection.,DEFENSE HOLDINGS INC,BUCKINGHAM THOMAS MARTIN;;ELGER WALLACE MICHAEL,DEFENSE HOLDINGS INC (2007-11-27),https://lens.org/192-363-604-565-164,Granted Patent,yes,12,8,13,13,0,B64C11/16;;B64C11/16;;B64C27/46;;B64C27/46;;C09D5/22;;C09D5/22,B05D5/00;;B64C11/16;;B05D1/00;;B64C27/46;;B64D47/02;;B64F1/20;;C09D5/22;;C09K/;;F21K2/00;;G01N21/84,427/64;;427/407.1,2,1,090-502-385-481-161,10.1109/iciasf.1995.519463,"Burns, S., and Sullivan, J., ""The Use of Pressure Sensitive Paint on Rotating Machinery,"" CH34827-95, IEEE 16th International Congress on Instrumentation in Aerospace Simulation Facilites (ICIASF), Wright-Patterson AFB, OH, 1995, pp. 32.1-32.14.;;Hazards of Rotating Propeller and Helicopter Rotor Blades; U.S. DOT, Federal Aviation Administration; Mar. 1993; entire document.",INACTIVE
13,ZA,B,ZA 883664 B,057-741-937-999-164,1989-03-29,1989,ZA 883664 A,1988-05-23,GB 8712105 A,1987-05-22,FILLERS,,ICI PLC,ASHLEY REGINALD JOYCE;;REGINALD JOYCE ASHLEY;;EVANS MARTIN BUCKINGHAM;;MARTIN BUCKINGHAM EVANS;;ROTHON ROGER NORMAN;;ROGER NORMAN ROTHON,,https://lens.org/057-741-937-999-164,Granted Patent,no,0,0,2,13,0,,C08K/;;C08L/,,0,0,,,,EXPIRED
14,ZA,B,ZA 883663 B,127-340-424-833-310,1989-03-29,1989,ZA 883663 A,1988-05-23,GB 8712106 A,1987-05-22,FILLERS,,ICI PLC,CAREY JOHN GERARD;;JOHN GERARD CAREY;;EVANS MARTIN BUCKINGHAM;;MARTIN BUCKINGHAM EVANS;;ROTHON ROGER NORMAN;;ROGER NORMAN ROTHON,,https://lens.org/127-340-424-833-310,Granted Patent,no,0,0,2,12,0,,C08K/;;C08L/,,0,0,,,,EXPIRED
15,EP,A2,EP 0292231 A2,078-178-349-501-974,1988-11-23,1988,EP 88304446 A,1988-05-17,GB 8712107 A;;GB 8714916 A,1987-05-22,Fillers.,"A cohesive polymer matrix comprising a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is a solution rubber, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of up to 3,000 which contains an acidic group (or a precursor thereof) and unsaturated groups optionally linked to the matrix polymer at least 25% w/w of which are vinyl groups.  ",ICI PLC,EVANS MARTIN BUCKINGHAM IVY CO;;ROTHON ROGER NORMAN,,https://lens.org/078-178-349-501-974,Patent Application,yes,0,2,10,13,0,C08K9/08;;C08K9/08,C08K9/00;;C08K9/04;;C08K9/08;;C08L23/16,,0,0,,,,DISCONTINUED
16,BE,A,BE 588053 A,168-175-697-625-155,1960-06-16,1960,BE 588053 A,1960-02-26,GB 686659 A,1959-02-27,"Matériau perfectionné, résistant à la chaleur et son procédé de fabrication.",,NAT RES DEV,PARR NORMAN LAWRENCE;;MARTIN GEORGE FRANK;;BUCKINGHAM JOHN,,https://lens.org/168-175-697-625-155,Granted Patent,no,0,0,11,13,0,C03C8/02;;C04B35/584;;C04B35/591;;C22C32/00;;C22C32/0047;;F01D5/284;;C04B35/584;;C04B35/591;;C22C32/00;;C03C8/02;;F01D5/284;;C22C32/0047,C03C8/02;;C04B35/584;;C04B35/591;;C22C32/00;;F01D5/28,,0,0,,,,EXPIRED
17,ZA,B,ZA 887900 B,179-972-980-717-267,1990-06-27,1990,ZA 887900 A,1988-10-21,GB 8724912 A,1987-10-23,THERAPEUTIC HETEROCYCLIC COMPOUNDS,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;ALAN DUNCAN ROBERTSON;;MARTIN GRAEME RICHARD;;GRAEME RICHARD MARTIN;;BUCKINGHAM JANET SUSAN;;JANET SUSAN BUCKINGHAM,,https://lens.org/179-972-980-717-267,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;C07D403/04;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
18,ES,T3,ES 2054825 T3,050-278-453-964-698,1994-08-16,1994,ES 88309943 T,1988-10-21,GB 8724912 A,1987-10-23,COMPUESTOS HETEROCICLICOS TERAPEUTICOS.,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/050-278-453-964-698,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/04;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
19,DK,A,DK 586588 A,135-373-544-479-943,1989-04-24,1989,DK 586588 A,1988-10-21,GB 8724912 A,1987-10-23,TERAPEUTISKE HETEROCYCLISKE FORBINDELSER,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/135-373-544-479-943,Patent Application,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;C07D403/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
20,CN,A,CN 1035113 A,068-881-335-995-848,1989-08-30,1989,CN 88108816 A,1988-10-21,GB 8724912 A,1987-10-23,THERAPEUTIC HETEROCYCLIC COMPOUNDS,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/068-881-335-995-848,Patent Application,no,0,1,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,C07D403/04;;A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
21,EP,A2,EP 0292233 A2,082-847-217-499-622,1988-11-23,1988,EP 88304448 A,1988-05-17,GB 8712105 A;;GB 8719165 A,1987-05-22,Fillers.,"A cohesive polymer matrix comprising a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is a cross-linked olefin/acrylic polymer, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of up to 200,000 which contains an acidic group (or a precursor thereof) and an unsaturated group optionally linked to the matrix polymer and a process for its production, and precursors thereof for use in the process.  ",ICI PLC,ASHLEY REGINALD JOYCE;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/082-847-217-499-622,Patent Application,yes,0,8,10,13,0,C08K9/08;;C08K9/08,C08K9/00;;C08K9/04;;C08L23/00;;C08K9/08,,0,0,,,,DISCONTINUED
22,AU,A,AU 1988/016511 A,188-791-456-600-664,1988-11-24,1988,AU 1988/016511 A,1988-05-20,GB 8712105 A;;GB 8719165 A,1987-05-22,FILLERS,,ICI PLC,ASHLEY REGINALD JOYCE;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/188-791-456-600-664,Patent Application,no,0,0,10,13,0,C08K9/08;;C08K9/08,C08L23/00;;C08K9/00;;C08K9/04;;C08K9/08,,0,0,,,,EXPIRED
23,AU,B2,AU 604165 B2,031-640-915-552-824,1990-12-06,1990,AU 1988/024181 A,1988-10-24,GB 8724912 A,1987-10-23,SUBSTITUTED INDOLE DERIVATIVES,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/031-640-915-552-824,Granted Patent,no,0,1,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,C07D403/04;;A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
24,DE,T2,DE 3881472 T2,074-095-985-390-436,1993-12-16,1993,DE 3881472 T,1988-10-21,GB 8724912 A,1987-10-23,Heterocyclische Verbindungen mit therapeutischer Wirkung.,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/074-095-985-390-436,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/04;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
25,AU,B2,AU 610890 B2,120-046-942-768-57X,1991-05-30,1991,AU 1988/016513 A,1988-05-20,GB 8712106 A;;GB 8714905 A,1987-05-22,FILLED COHESIVE POLYMER MATRICES,,ICI PLC,CAREY JOHN GERARD;;ROTHON ROGER NORMAN;;EVANS MARTIN BUCKINGHAM,,https://lens.org/120-046-942-768-57X,Granted Patent,no,1,0,9,12,0,C08K9/08;;C08K9/08,C08K9/04;;C08K9/00;;C08K9/08;;C08L9/00;;C08L21/00;;C09C3/10,,0,0,,,,EXPIRED
26,HU,A,HU T50163 A,141-272-169-056-678,1989-12-28,1989,HU 543188 A,1988-10-21,GB 8724912 A,1987-10-23,PROCESS FOR PRODUCTION OF DERIVATIVES OF INDOLE AND MEDICAL COMPOSITIONS CONTAINING THEM AS ACTIVE SUBSTANCE,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN D;;MARTIN GRAEME R;;BUCKINGHAM JANET S,,https://lens.org/141-272-169-056-678,Unknown,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;C07D403/04;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
27,NZ,A,NZ 224737 A,126-300-526-021-476,1990-03-27,1990,NZ 22473788 A,1988-05-20,GB 8714905 A;;GB 8712106 A,1987-05-22,COHESIVE POLYMER MATRIX OF AN EMULSION RUBBER CONTAINING DISPERSED COATED PARTICLES,,ICI PLC,CAREY JOHN GERARD;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/126-300-526-021-476,Patent Application,no,0,0,9,12,0,C08K9/08;;C08K9/08,C08K9/04;;C08K9/00;;C08K9/08;;C08L9/00;;C08L21/00;;C09C3/10,,0,0,,,,DISCONTINUED
28,EP,A3,EP 0292233 A3,138-937-175-000-393,1989-01-25,1989,EP 88304448 A,1988-05-17,GB 8712105 A;;GB 8719165 A,1987-05-22,FILLERS,"A cohesive polymer matrix comprising a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is a cross-linked olefin/acrylic polymer, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of up to 200,000 which contains an acidic group (or a precursor thereof) and an unsaturated group optionally linked to the matrix polymer and a process for its production, and precursors thereof for use in the process.  ",IMPERIAL CHEMICAL INDUSTRIES PLC,"ASHLEY, REGINALD JOYCE;;EVANS, MARTIN BUCKINGHAM;;ROTHON, ROGER NORMAN",,https://lens.org/138-937-175-000-393,Search Report,yes,3,0,10,13,0,C08K9/08;;C08K9/08,C08K9/00;;C08K9/04;;C08L23/00;;C08K9/08,,0,0,,,,DISCONTINUED
29,US,A,US 5225431 A,161-197-643-024-349,1993-07-06,1993,US 66096691 A,1991-02-26,US 66096691 A;;GB 8724912 A;;US 26088588 A,1987-10-23,Therapeutic substituted indole compounds and compositions thereof,"The present invention is concerned with compounds of formula (I) ##STR1## wherein R, R.sup.1 and R.sup.2 are independently selected from hydrogen and C.sub.1-4 alkyl; R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C.sub.1-4 alkyl and aryl), provided R.sup.3 benzyl or substituted benzyl when R.sup.4 =H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) ##STR2## wherein Y is selected from oxygen, methylene and &gt;N--R.sup.5, where R.sup.5 is hydrogen, C.sub.1-4 alkyl, or benzyl, Z and Z' are independently selected from &gt;C.dbd.O, &gt;C.dbd.S and methylene, and the chiral center * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",BURROUGHS WELLCOME CO,ROBERTSON ALAN D;;MARTIN GRAEME R;;BUCKINGHAM JANET S,,https://lens.org/161-197-643-024-349,Granted Patent,yes,41,8,1,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;C07D403/06;;C07D409/14;;C07D405/14;;C07D413/06;;C07D209/16,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06,514/389;;514/391;;548/312.1,4,3,055-832-974-979-665;;034-093-681-017-560;;065-155-352-811-347,10.1021/jo01021a035;;10.1016/s0140-6736(88)92122-8;;10.2165/00003088-198510040-00004;;3899452,"Keery et al., Brit. J. Pharm., vol. 89 (Supplement), p. 834p, (1986).;;Finkbeiner, H., J. Org. Chem., vol. 30(10), pp. 3414 3419 (1965).;;A. Doenicke, et al., The Lancet, Jun. 11, 1988, pp. 1309 1311.;;V. L. Perrin, Clinical Pharmacokinetics 10: pp. 334 352, (1985).",EXPIRED
30,AU,A,AU 1988/024181 A,012-421-361-432-193,1989-04-27,1989,AU 1988/024181 A,1988-10-24,GB 8724912 A,1987-10-23,SUBSTITUTED INDOLE DERIVATIVES,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/012-421-361-432-193,Patent Application,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,C07D403/04;;A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
31,MC,A1,MC 1983 A1,096-776-515-425-923,1989-11-23,1989,MC 2012 A,1988-10-21,GB 8724912 A,1987-10-23,"COMPOSES HETEROCYCLIQUES,LEUR PREPARATION ET MEDICAMENTS QUI CONTIENNENT DE TELS COMPOSES","The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ALAN DUNCAN ROBERTSON;;GRAEME RICHARD MARTIN;;JANET SUSAN BUCKINGHAM,,https://lens.org/096-776-515-425-923,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;C07D403/04;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
32,EP,B1,EP 0313397 B1,144-797-319-547-634,1993-06-02,1993,EP 88309943 A,1988-10-21,GB 8724912 A,1987-10-23,THERAPEUTIC HETEROCYCLIC COMPOUNDS,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",THE WELLCOME FOUNDATION LIMITED,"ROBERTSON, ALAN DUNCAN;;MARTIN, GRAEME RICHARD;;BUCKINGHAM, JANET SUSAN",THE WELLCOME FOUNDATION LIMITED (1990-08-16),https://lens.org/144-797-319-547-634,Granted Patent,yes,2,1,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/04;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
33,DE,D1,DE 3881472 D1,164-135-450-084-164,1993-07-08,1993,DE 3881472 T,1988-10-21,GB 8724912 A,1987-10-23,HETEROCYCLISCHE VERBINDUNGEN MIT THERAPEUTISCHER WIRKUNG.,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/164-135-450-084-164,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/04;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
34,EP,A1,EP 0313397 A1,012-242-717-691-556,1989-04-26,1989,EP 88309943 A,1988-10-21,GB 8724912 A,1987-10-23,Therapeutic heterocyclic compounds.,"The present invention is concerned with compounds o formula (I)
  wherein
 R, R 1  and R 2  are independently selected from hydrogen and C 1-4  alkyl; R 3  and R 4  are independently selected from hydrogen, C 1-6  alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, Ci-4 alkyl and aryl), provided R 3  ≠ benzyl or substituted benzyl when R 4  = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv)
  wherein Y is selected from oxygen, methylene and N-R 5 , where R 5  is hydrogen, Ci- 4  alkyl, or benzyl, Z and Z' are independently selected from  C=O,  C-S and methylene, and the chiral centre  *  in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C 1-6  alkyl (including cycloalkyl) aryl (including heteroaryl) Ci-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C 1-4  alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,THE WELLCOME FOUNDATION LIMITED (1990-08-16),https://lens.org/012-242-717-691-556,Patent Application,yes,4,98,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/04;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
35,BR,A,BR 8802515 A,175-128-165-963-294,1988-12-20,1988,BR 8802515 A,1988-05-23,GB 8712106 A;;GB 8714905 A,1987-05-22,MATRIZ POLIMERICA COESIVA E PROCESSO PARA A PRODUCAO DE UMA MATRIZ DE BORRACHA EM EMULSAO COESIVA RECHEADA,,ICI PLC,CAREY JOHN GERARD;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/175-128-165-963-294,Patent Application,no,0,0,9,12,0,C08K9/08;;C08K9/08,C08K9/04;;C08K9/00;;C08K9/08;;C08L9/00;;C08L21/00;;C09C3/10,,0,0,,,,DISCONTINUED
36,NZ,A,NZ 226671 A,195-862-902-911-139,1991-09-25,1991,NZ 22667188 A,1988-10-21,GB 8724912 A,1987-10-23,"INDOLE DERIVATIVES HAVING SUBSTITUENT GROUP CONTAINING IMIDAZOLE, PYRROLE AND OPTIONALLY XANTHENYL GROUPINGS; PHARMACEUTICAL COMPOSITIONS","The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/195-862-902-911-139,Patent Application,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D403/04;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
37,BR,A,BR 8802514 A,185-201-249-714-325,1988-12-20,1988,BR 8802514 A,1988-05-23,GB 8712105 A;;GB 8719165 A,1987-05-22,"MATRIZ POLIMERICA COESIVA,COMPOSICAO PRECURSORA PARA UMA MATRIZ,MATRIZ RESISTENTE AO FOGO E PROCESSO PARA A PRODUCAO DE UMA MATRIZ POLIMERICA COESIVA",,ICI PLC,ASHLEY REGINALD JOYCE;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/185-201-249-714-325,Patent Application,no,0,0,10,13,0,C08K9/08;;C08K9/08,C08L23/00;;C08K9/00;;C08K9/04;;C08K9/08,,0,0,,,,DISCONTINUED
38,AU,B2,AU 603671 B2,041-958-897-956-149,1990-11-22,1990,AU 1988/016511 A,1988-05-20,GB 8712105 A;;GB 8719165 A,1987-05-22,FILLERS,,ICI PLC,ASHLEY REGINALD JOYCE;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/041-958-897-956-149,Granted Patent,no,3,0,10,13,0,C08K9/08;;C08K9/08,C08L23/00;;C08K9/00;;C08K9/04;;C08K9/08,,0,0,,,,EXPIRED
39,EP,A3,EP 0292231 A3,077-221-749-111-136,1990-12-12,1990,EP 88304446 A,1988-05-17,GB 8712107 A;;GB 8714916 A,1987-05-22,FILLERS,"A cohesive polymer matrix comprising a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is a solution rubber, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of up to 3,000 which contains an acidic group (or a precursor thereof) and unsaturated groups optionally linked to the matrix polymer at least 25% w/w of which are vinyl groups.  ",IMPERIAL CHEMICAL INDUSTRIES PLC,"EVANS, MARTIN BUCKINGHAM 1 IVY COTTAGES;;ROTHON, ROGER NORMAN",,https://lens.org/077-221-749-111-136,Search Report,yes,4,0,10,13,0,C08K9/08;;C08K9/08,C08K9/00;;C08K9/04;;C08K9/08;;C08L23/16,,0,0,,,,DISCONTINUED
40,DK,D0,DK 586588 D0,101-446-208-354-421,1988-10-21,1988,DK 586588 A,1988-10-21,GB 8724912 A,1987-10-23,TERAPEUTISKE HETEROCYCLISKE FORBINDELSER,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/101-446-208-354-421,Patent Application,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;C07D403/04;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
41,DD,A5,DD 283140 A5,058-082-716-987-215,1990-10-03,1990,DD 32094088 A,1988-10-21,GB 8724912 A,1987-10-23,VERFAHREN ZUR HERSTELLUNG VON THERAPEUTISCHEN HETEROZYCLISCHEN VERBINDUNGEN,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN D;;MARTIN GRAEME R;;BUCKINGHAM JANET S,,https://lens.org/058-082-716-987-215,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,C07D403/04;;A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
42,FI,A0,FI 884879 A0,072-311-393-440-47X,1988-10-21,1988,FI 884879 A,1988-10-21,GB 8724912 A,1987-10-23,TERAPEUTISKT ANVAENDBARA HETEROCYKLISKA FOERENINGAR.,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/072-311-393-440-47X,Patent Application,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;C07D403/04;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
43,PT,B,PT 88829 B,161-281-130-590-291,1993-01-29,1993,PT 8882988 A,1988-10-21,GB 8724912 A,1987-10-23,"PROCESSO PARA A PREPARACAO DE DERIVADOS DE 2-{5-(2,5-DIOXOIMIDAZOLIDIN-4-ILMETIL)-1H-INDOL-3-IL}ETILAMINA","The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/161-281-130-590-291,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;C07D403/04;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
44,AU,A,AU 1988/016513 A,047-678-745-890-445,1988-11-24,1988,AU 1988/016513 A,1988-05-20,GB 8712106 A;;GB 8714905 A,1987-05-22,FILLERS,,ICI PLC,CAREY JOHN GERARD;;EVANS MARTIN BUCKINGHAM;;ROTHON ROGER NORMAN,,https://lens.org/047-678-745-890-445,Patent Application,no,0,0,9,12,0,C08K9/08;;C08K9/08,C08K9/04;;C08K9/00;;C08K9/08;;C08L9/00;;C08L21/00;;C09C3/10,,0,0,,,,EXPIRED
45,FI,A,FI 884879 A,040-508-730-233-868,1989-04-24,1989,FI 884879 A,1988-10-21,GB 8724912 A,1987-10-23,TERAPEUTISKT ANVAENDBARA HETEROCYKLISKA FOERENINGAR.,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/040-508-730-233-868,Patent Application,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;C07D403/04;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
46,HU,B,HU 202230 B,062-253-336-142-761,1991-02-28,1991,HU 543188 A,1988-10-21,GB 8724912 A,1987-10-23,PROCESS FOR PRODUCING INDOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE COMPONENTS,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/062-253-336-142-761,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;C07D403/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,EXPIRED
47,AT,T1,AT E90089 T1,093-879-560-388-108,1993-06-15,1993,AT 88309943 T,1988-10-21,EP 88309943 A;;GB 8724912 A,1987-10-23,HETEROCYCLISCHE VERBINDUNGEN MIT THERAPEUTISCHER WIRKUNG.,"The present invention is concerned with compounds of formula (I) <CHEM> wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H; m is an integer of from 0 to 2; n is an integer of from 0 to 3; (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions; X is a group selected from aryl (including heteroaryl) xanthenyl dibenzofuranyl which group is optionally substituted by an atom or group selected from C1-6 alkyl (including cycloalkyl) aryl (including heteroaryl) C1-4 alkoxy aryloxy alkylsulphonyl arylsulphonyl halogen cyano carbamoyl alkylcarbamoyl dialkylcarbamoyl arylcarbamoyl diarylcarbamoyl carbamoylmethyl N-alkylcarbamoylmethyl N,N-dialkylcarbamoylmethyl N-arylcarbamoylmethyl N,N-diarylcarbamoylmethyl alkoylamino aroylamino alkoylaminomethyl aroylaminomethyl alkylsulphamino arylsulphamino alkylsulphaminomethyl arylsulphaminomethyl sulphamyl alkylsulphamyl dialkylsulphamyl arylsulphamyl diarysulphamyl the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.",WELLCOME FOUND,ROBERTSON ALAN DUNCAN;;MARTIN GRAEME RICHARD;;BUCKINGHAM JANET SUSAN,,https://lens.org/093-879-560-388-108,Granted Patent,no,0,0,26,27,0,C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/06;;A61P25/04;;A61P25/06;;A61P9/00,C07D403/04;;A61K31/40;;A61K31/41;;A61K31/415;;A61K31/42;;A61P9/00;;A61P25/04;;A61P25/06;;C07D209/16;;C07D403/06;;C07D405/14;;C07D409/14;;C07D413/04;;C07D413/06,,0,0,,,,DISCONTINUED
48,EP,A3,EP 0292232 A3,050-641-445-338-375,1990-12-12,1990,EP 88304447 A,1988-05-17,GB 8712106 A;;GB 8714905 A,1987-05-22,FILLERS,"A cohesive polymer matrix comprising a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is an emulsion rubber, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of 4,500 to 200,000, which contains an acidic group (or a precursor thereof) and an unsaturated group, optionally linked to the matrix polymer and a process for its production.  ",IMPERIAL CHEMICAL INDUSTRIES PLC,"CAREY, JOHN GERARD ST. ANN'S;;EVANS, MARTIN BUCKINGHAM 1 IVY COTTAGES;;ROTHON, ROGER NORMAN",,https://lens.org/050-641-445-338-375,Search Report,yes,4,0,9,12,0,C08K9/08;;C08K9/08,C08K9/04;;C08K9/00;;C08K9/08;;C08L9/00;;C08L21/00;;C09C3/10,,0,0,,,,DISCONTINUED
49,EP,A2,EP 0292232 A2,020-725-531-403-049,1988-11-23,1988,EP 88304447 A,1988-05-17,GB 8712106 A;;GB 8714905 A,1987-05-22,Fillers.,"A cohesive polymer matrix comprising a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is an emulsion rubber, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of 4,500 to 200,000, which contains an acidic group (or a precursor thereof) and an unsaturated group, optionally linked to the matrix polymer and a process for its production.  ",ICI PLC,CAREY JOHN GERARD ST ANN S;;EVANS MARTIN BUCKINGHAM IVY CO;;ROTHON ROGER NORMAN,,https://lens.org/020-725-531-403-049,Patent Application,yes,0,2,9,12,0,C08K9/08;;C08K9/08,C08K9/04;;C08K9/00;;C08K9/08;;C08L9/00;;C08L21/00;;C09C3/10,,0,0,,,,DISCONTINUED
